![Performance of Restricted Mean Survival Time Based Methods and Traditional Survival Methods: An Application in an Oncological Data Performance of Restricted Mean Survival Time Based Methods and Traditional Survival Methods: An Application in an Oncological Data](https://static-02.hindawi.com/articles/cmmm/volume-2022/7264382/figures/7264382.fig.002.jpg)
Performance of Restricted Mean Survival Time Based Methods and Traditional Survival Methods: An Application in an Oncological Data
![Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome | BMC Medical Research Methodology | Full Text Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2288-13-152/MediaObjects/12874_2013_Article_1188_Fig1_HTML.jpg)
Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome | BMC Medical Research Methodology | Full Text
![Cancers | Free Full-Text | Adherence to Treatment Guidelines and Associated Survival in Older Patients with Prostate Cancer: A Prospective Multicentre Cohort Study Cancers | Free Full-Text | Adherence to Treatment Guidelines and Associated Survival in Older Patients with Prostate Cancer: A Prospective Multicentre Cohort Study](https://www.mdpi.com/cancers/cancers-13-04694/article_deploy/html/images/cancers-13-04694-g002.png)
Cancers | Free Full-Text | Adherence to Treatment Guidelines and Associated Survival in Older Patients with Prostate Cancer: A Prospective Multicentre Cohort Study
![The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt - Royston - 2011 - Statistics in Medicine - Wiley Online Library The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt - Royston - 2011 - Statistics in Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/51766eca-cc06-485f-90be-a1ee7ac0564d/sim4274-fig-0006-m.jpg)
The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt - Royston - 2011 - Statistics in Medicine - Wiley Online Library
![Using the Restricted Mean Survival Time Difference as an Alternative to the Hazard Ratio for Analyzing Clinical Cardiovascular Studies | Circulation Using the Restricted Mean Survival Time Difference as an Alternative to the Hazard Ratio for Analyzing Clinical Cardiovascular Studies | Circulation](https://www.ahajournals.org/cms/asset/2130035e-4ca7-4341-a6eb-e64b80004f96/1366fig01.gif)
Using the Restricted Mean Survival Time Difference as an Alternative to the Hazard Ratio for Analyzing Clinical Cardiovascular Studies | Circulation
![cox model - Restricted Mean Survival Time vs Hazard Ratio - How to describe the differences? - Cross Validated cox model - Restricted Mean Survival Time vs Hazard Ratio - How to describe the differences? - Cross Validated](https://i.stack.imgur.com/4jB8s.png)
cox model - Restricted Mean Survival Time vs Hazard Ratio - How to describe the differences? - Cross Validated
![PDF] Restricted mean survival time for the analysis of cardiovascular outcome trials assessing non-inferiority: Case studies from antihyperglycemic drug development. | Semantic Scholar PDF] Restricted mean survival time for the analysis of cardiovascular outcome trials assessing non-inferiority: Case studies from antihyperglycemic drug development. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3e44c5c7f36a8a9cef47c5c948c038c62cc29280/4-Figure1-1.png)
PDF] Restricted mean survival time for the analysis of cardiovascular outcome trials assessing non-inferiority: Case studies from antihyperglycemic drug development. | Semantic Scholar
![Analyzing differences between restricted mean survival time curves using pseudo-values | BMC Medical Research Methodology | Full Text Analyzing differences between restricted mean survival time curves using pseudo-values | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-022-01559-z/MediaObjects/12874_2022_1559_Fig2_HTML.png)
Analyzing differences between restricted mean survival time curves using pseudo-values | BMC Medical Research Methodology | Full Text
![Visualization of restricted mean survival time analysis. a Restricted... | Download Scientific Diagram Visualization of restricted mean survival time analysis. a Restricted... | Download Scientific Diagram](https://www.researchgate.net/publication/348291893/figure/fig2/AS:985746294992898@1612031639362/sualization-of-restricted-mean-survival-time-analysis-a-Restricted-mean-survival-time.png)
Visualization of restricted mean survival time analysis. a Restricted... | Download Scientific Diagram
![Restricted mean survival time (RMST) as the area under the curve. (A)... | Download Scientific Diagram Restricted mean survival time (RMST) as the area under the curve. (A)... | Download Scientific Diagram](https://www.researchgate.net/publication/338409820/figure/fig1/AS:1015208449437700@1619055964354/Restricted-mean-survival-time-RMST-as-the-area-under-the-curve-A-Reconstructed.png)
Restricted mean survival time (RMST) as the area under the curve. (A)... | Download Scientific Diagram
![Comparison of the restricted mean survival time with the hazard ratio in superiority trials with a time‐to‐event end point - Huang - 2018 - Pharmaceutical Statistics - Wiley Online Library Comparison of the restricted mean survival time with the hazard ratio in superiority trials with a time‐to‐event end point - Huang - 2018 - Pharmaceutical Statistics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2dcb7355-af71-40a7-a5bc-e95d8a274f41/pst1846-fig-0003-m.jpg)
Comparison of the restricted mean survival time with the hazard ratio in superiority trials with a time‐to‐event end point - Huang - 2018 - Pharmaceutical Statistics - Wiley Online Library
![Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation - ScienceDirect Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213177920304558-fx1ad.jpg)
Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation - ScienceDirect
![Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation - ScienceDirect Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213177920304558-fx1ef.jpg)
Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation - ScienceDirect
![Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials? - Theodore Karrison, Masha Kocherginsky, 2018 Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials? - Theodore Karrison, Masha Kocherginsky, 2018](https://journals.sagepub.com/cms/10.1177/1740774518759281/asset/images/large/10.1177_1740774518759281-fig1.jpeg)